Welcome to biotech where is costs a lot to bring a drug to market and a long time.
Cost to Develop New Pharmaceutical Drug Now Exceeds $2.5B. A new report published by the Tufts Center for the Study of Drug Development (CSDD) pegs the cost of developing a prescription drug that gains market approval at $2.6 billion, a 145% increase, correcting for inflation, over the estimate the center made in 2003.Nov 24, 2014
CSDD’s finding, a bellwether figure in the drug industry, is based on an average out-of-pocket cost of $1.4 billion and an estimate of $1.2 billion in returns that investors forego on that money during the 10-plus years a drug candidate spends in development.
The study concludes that another $312 million is spent on postapproval development—studies to test new indications, formulations, and dosage strengths—for a life-cycle cost of $2.9 billion.
Realist, I recall, the last quarterly report posted total PPHM operating losses have accumulated to about $550 million. That amounts to about $2 per share. What is that offsetting loss worth to a profitable Pharma if PPHM is acquired?
Market Data 
Markets 
AI
